Patents by Inventor Amy Holt

Amy Holt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR ENHANCING VISUAL FUNCTION
    Publication number: 20200339641
    Abstract: The present disclosure provides a method of restoring or enhancing visual function in an individual, the method comprising administering to the individual a nucleic acid comprising a nucleotide sequence encoding one or more of a medium wavelength cone opsin (MW-opsin), a long wavelength cone opsin (LW-opsin), and a short wavelength cone opsin (SW-opsin). One or more of the MW-opsin, LW-opsin, and SW-opsin is expressed in a retinal cell in the individual, thereby restoring or enhancing visual function.
    Type: Application
    Filed: July 6, 2020
    Publication date: October 29, 2020
    Inventors: Ehud Y. Isacoff, Michael H. Berry, Amy Holt, Meike Visel, Autoosa Salari, John G. Flannery, Benjamin M. Gaub
  • Compositions and methods for enhancing visual function
    Patent number: 10745453
    Abstract: The present disclosure provides a method of restoring or enhancing visual function in an individual, the method comprising administering to the individual a nucleic acid comprising a nucleotide sequence encoding one or more of a medium wavelength cone opsin (MW-opsin), a long wavelength cone opsin (LW-opsin), and a short wavelength cone opsin (SW-opsin). One or more of the MW-opsin, LW-opsin, and SW-opsin is expressed in a retinal cell in the individual, thereby restoring or enhancing visual function.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: August 18, 2020
    Assignee: The Regents of the University of California
    Inventors: Ehud Y. Isacoff, Michael H. Berry, Amy Holt, Meike Visel, Autoosa Salari, John G. Flannery, Benjamin M. Gaub
  • Isolation and identification of transcription control elements associated with mouse eosinophil peroxidase expression
    Patent number: 7115793
    Abstract: The present invention relates to novel transcription control elements derived from a mouse eosinophil peroxidase gene. Such transcription control elements may comprise isolated polynucleotides, expression cassettes, vectors, recombinant cells, and transgenic animals, as described herein.
    Type: Grant
    Filed: November 16, 2004
    Date of Patent: October 3, 2006
    Assignee: Xenogen Corporation
    Inventors: Hongbing Zhang, Pamela Contag, Anthony Purchio, Amy Holt
  • Isolation and identification of transcription control elements associated with mouse eosinophil peroxidase expression
    Publication number: 20050138678
    Abstract: The present invention relates to novel transcription control elements derived from a mouse eosinophil peroxidase gene. Such transcription control elements may comprise isolated polynucleotides, expression cassettes, vectors, recombinant cells, and transgenic animals, as described herein.
    Type: Application
    Filed: November 16, 2004
    Publication date: June 23, 2005
    Inventors: Hongbing Zhang, Pamela Contag, Anthony Purchio, Amy Holt
  • Transgenic mice comprising transcription control elements associated with mouse eosinophil peroxidase expression
    Patent number: 6858773
    Abstract: The present invention relates to novel transcription control elements derived from a mouse eosinophil peroxidase gene. The novel transcription control elements described in the disclosure may comprise isolated polynucleotides, expression cassettes, vectors, recombinant cells, and transgenic animals.
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: February 22, 2005
    Assignee: Xenogen Corporation
    Inventors: Hongbing Zhang, Pamela Contag, Anthony Purchio, Amy Holt
  • Isolation and identification of transcription control elements associated with mouse eosinophil peroxidase expression
    Publication number: 20030005472
    Abstract: The present invention relates to novel transcription control elements derived from a mouse eosinophil peroxidase gene. Such transcription control elements may comprise isolated polynucleotides, expression cassettes, vectors, recombinant cells, and transgenic animals, as described herein.
    Type: Application
    Filed: April 19, 2002
    Publication date: January 2, 2003
    Inventors: Hongbing Zhang, Pamela Contag, Anthony Purchio, Amy Holt